About HKTDC | Media Room | Contact HKTDC | Wish List Wish List () | My HKTDC |
繁體 简体
Save As PDF Email this page Print this page
Qzone

INDIA: Re-designated Medical Devices Now Subject to Drug Price Regulation Regime

Certain medical devices may now be re-classified as drugs at the discretion of the Ministry of Health. All such re-designated devices will then fall within the remit of the Ministry’s price regulation regime and will also be liable to undergo pre-launch clinical trials in compliance with the country’s recently promulgated Medical Devices Rules, due to come into effect as of 1 January 2018.

In the first tranche of re-designations, 15 medical devices have been re-classified –  vitro diagnostic devices for HIV, HbsAg and HCV; cardiac stents; drug eluting stents; catheters; intra-ocular lenses; I.V. Cannulae; heart valves; bone cements; scalp vein sets; orthopaedic implants; internal prosthetic replacements; ablation devices; disposable perfusion sets; and disposable hypodermic syringes and needles.

Content provided by Picture: HKTDC Research
Comments (0)
Shows local time in Hong Kong (GMT+8 hours)

HKTDC welcomes your views. Please stay on topic and be respectful of other readers.
Review our Comment Policy

*Add a comment (up to 5,000 characters)